BackMedicinova Overview

Medicinova Current Cash

Track Medicinova's current cash ($25B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$25.42B
↑ 74086.19% YoYΔ $25.38B vs prior year quarter

Peer trimmed avg / median

Loading

Medicinova Current Cash History

Loading

Medicinova vs. peers: Current Cash Comparison

Loading

Medicinova Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Medicinova (MNOV) FAQ

Medicinova (MNOV) currently reports a current cash of $25B as of June 2026. That compares with $34M in the prior-year period — up 74086.2% year over year. Use the charts on this page to explore Medicinova's current cash history and peer comparisons.

Medicinova's current cash increased from $34M to $25B — a 74086.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medicinova reported $25B in current cash as of June 2026. That compares with $34M in the prior-year period — up 74086.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $25B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medicinova, and consider following MNOV for alerts when major investors trade the stock.

Medicinova is classified in the Healthcare sector. On current cash, it currently shows $25B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MNOV with unrelated industries.